Почетна › Неинвазивни карцином бешике › Њујорк
Kliničke studije za Неинвазивни карцином бешике u državi Њујорк
17 studija za Неинвазивни карцином бешике traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
- New York City10 студија
- Syracuse9 студија
- Queens4 студија
- Staten Island4 студија
- Greenburgh4 студија
- New Rochelle3 студија
- Buffalo3 студија
- The Bronx3 студија
Zvanični tekst studije (na engleskom)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Commack, Commack
- MSK Westchester, Harrison
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- и још 9
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07206225FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- и још 4
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Medical Professionals, Syracuse
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06919965A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- SUNY Upstate Med Univ, Syracuse
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07309445Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
- и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06995677A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- SUNY Upstate Medical University, Syracuse
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07725796A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical Center, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT06503614Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06833073A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- Roswell Park Comprehensive Cancer Center, Buffalo
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT06733363Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT05951179A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), East White Plains
- Columbia University (Data Collection Only), New York
- и још 2
Тражи се учесникФаза 3
Узраст 21 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06929286Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT05126472LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- SUNY Upstate Medical University, Syracuse
Тражи се учесникФаза 1/2
Узраст од 18 до 85 · Оба пола · Ажурирано 27. 3. 2026. · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- NYU Langone's Perlmutter Cancer Center, New York
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 18. 12. 2025. · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 11. 2025. · NCT03945162Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.